Herbal medicine in treatment of mental disorders;Prirodni lijekovi u terapiji mentalnih poremećaja

Medicus

Volumn 11, Issue 2, 2002, Pages 263-269

  Jakovljević, Miro ^a   Mihaljević Peleš, Alma ^a   Šagud, Marina ^a   Rajačić, Miro ^b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b PLIVA CROATIA LTD   (Croatia)

Author keywords

Ginkgo biloba; Ginseng; Kava kava; Melatonin; Natural medications; Omega 3 fatty acids; Psychiatric disorders; St. John's wort; Valerian; Vitamine B, E, phosphatidylserin

Indexed keywords

ALPHA TOCOPHEROL; ANTIDEPRESSANT AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CARBAMAZEPINE; CONTRACEPTIVE AGENT; CYCLOSPORIN; DIGOXIN; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; INDINAVIR; KAVA; MELATONIN; NEUROLEPTIC AGENT; OMEGA 3 FATTY ACID; PHENOBARBITAL; PHENYTOIN; PHOSPHATIDYLSERINE; SEROTONIN UPTAKE INHIBITOR; THEOPHYLLINE; UNCLASSIFIED DRUG; VALERIAN; VITAMIN B GROUP; WARFARIN;

ALTERNATIVE MEDICINE; ARTICLE; CLINICAL TRIAL; CROATIA; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG MECHANISM; ECG ABNORMALITY; EVIDENCE BASED MEDICINE; GASTROINTESTINAL SYMPTOM; HERBAL MEDICINE; HUMAN; HYPERTENSION; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDLINE; MENTAL DISEASE; PATIENT; PHOTOSENSITIVITY; PHYSICIAN; PRIMARY MEDICAL CARE; SIDE EFFECT; STEVENS JOHNSON SYNDROME; VERTIGO;

EID: 0036961186     PISSN: 1330013X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. BLOOMFIELD H. Healing Anxiety with Herbs. Thorsons. An Imprint of HarperCollins Publishers, 1998.
2. VRHOVAC B. Važnost kliničke farmakologije za obiteljskog liječnika u nas. MEDICUS 2002; 11:7-11.
3. JAKOVLIEVIĆ M. Prirodni (biljni) lijekovi s anksiolitičkim učinkom. U: Jakovljević M, Lacković Z i sur. (ur.) Benzodiazepini u suvremenoj medicini, Zagreb; Medicinska naklada 2001; 238-45.
4. CHATTERJEE SS, NOELDNER M, KOCH E, ERDELMEIER C. Antidepressant Activity of Hypericum Perforatum and Hyperforin: The Neglected Possibility. Pharmacopsychiatry 1998; 31 (Suppl): 7-15.
5. LaFRANCE WC, LAUTERBACH E, COFFEY CE, SALLOWAY SP, KAUFER DI, REEVE A, RPYAL DR, AYLWARD E, RUMMANS T, LOVELL MR. The Use of Herbal Alternative Medicines in Nueropsychiatry. J Neuropsychiatry Clin Neurosci 2000; 12: 177-92.
6. VORBACH EU, ARNOLD KH, HUBNER WD. Efficacy and Tolerability of St. John's Wort Extract LI 160 versus Imipramine in Patients with Severe Depression Episodes According to ICD-10. Pharmacopsychiatry, 1997; 30: 81-5.
7. BRENNER R, AZBEL V, MADHUSOODANAN S, et al. Comparison of an Extract of Hypericum (LI 160) and Sertraline in the Treatment of Depression: A Double-Blind Randomized Pilot Study. Clin Ther 2000; 22: 411-9.
8. SCHRÄDER E: Equivalence of St. John's Wort Extract (Ze117) and Fluoxetine: A randomized, Controlled Study in Mild-Moderate Depression. Int Clin Psychopharmacol 2000; 15: 61-8.
9. SHELTON RC, KELLER MB, GELENBERG A et al. Effectiveness of St. John's Wort in Major Depression: A Randomized Controlled Trial. JAMA 2001; 285: 1978-86.
10. Hypericum Depression Trial Study Group: Effect of Hypericum Perforatum (St. John's Wort) in Major Depressive Disorder. JAMA 2002; 287: 1807-14.
11. BILIA AR, GALLORI S & VINCIERI FF. St. John's Wort and Depression - Efficacy, Safety and Tolerability: An Update Minireview. Life Sciences, 2002; 70: 3077-3096.
12. Van GURP G, METERISSIAN GB, HAIEK LN, MCCUSKER J, BELLAVANCE F. St. John's Wort or Sertraline? Randomized Controlled Trial in Primary Care. Can Fam Physician 2002; 48: 905-12.
13. BEHNKE K, JENSEN GS, GRAUBAUM HJ, GRUENWALD J. Hypericum Perforatum versus Fluoxetine in the Treatment of Mild to Moderate Depression. Adv Ther 2002; 19: 43-52.
14. BROCKMOLLER J, REUM T, BAUER S, et al. Hypericin and Pseudohypericin: Pharmacokinetics and Effects on Photosensitivity in Humans. Pharmacopsychiatry 1997; 30: 94-101.
15. CZEKALLA J, HUBNER WD, JAGER D. The Effect of Hypericum Extract on Cardiac Conduction as Seen in the Electrocardiogram Compared to That of Imipramine. Pharmacopsychiatry 1997; 30: 86-8.
16. NIERENBERG AA, MISCHOULON D, DeCECCO L. St. John's Wort - A Critique of Antidepressant Efficacy and Possible Mechanisms of Action. In: Mischoulon D, Rosenbaum JF (eds.): Natural Medications for Psychiatric Disorders - Considering the Alternatives Philadelphia Lippincott Williams & Wilkins, 2002; 3-12.
17. MUELLER WE, SINGER A, WONNEMANN M, HAFNER U, ROLLI M, SCHAEFER C. Hyperforin Represents the Neurotransmitter Reuptake Inhibiting Constituent of Hypericum Extract. Parmacopsychiatry 1998 (Suppl); 31: 16-21.
18. LAAKMANN G, SCHUELE C, BAGHAI T, KIESER M. St. John's Wort in Mild to Moderate Depression: The Relevance of Hyperforin for the Clinical Efficacy. Pharmacopsyxchiatry 1998; 31(Suppl): 54-9.
19. LECRUBIER Y, CLERC G, DIDI R, KIESER M. Efficacy of St. John's Wort Extract WS 5570 in Major Depression: A Double-Blind, Placebo-Controlled Trial. Am J Psychiatry 2002; 159: 1361-66.
20. VOLTZ HP, KIESER M. Kava-kava extract WS 1490 versus placebo in anxiety disorders: a randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry 1997; 30: 1-5.
21. ITIL TM, ERALP E, TSAMBIS E et al. Central Nervous System Effects of Ginkgo Biloba, a Plant Extract. Am J Therapeutics 1996; 3: 63-73.
22. KULIER I. Suplementi u prehrani i športu. In press, Zagreb, 2002.
23. LeBARS PL, KATZ MM, Berman N et al. A Placebo-controlled, Double blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia. Journal of the American Medical Association 1997; 278: 1327-32.
24. KANOWSKY S, HERMAN W, STEPHAN K et al. Proof of Efficacy of the Ginkgo Biloba Special Extract Egb 761 in Outpatients Suffering from Mild to Moderate Primary Degenerative Dementia of the Alzheimer Type or Multiinfarct Dementia. Pharmacopsychiatry 1996; 29: 47-56.
25. SCHUBERT H, HALAMA P. Depressive Episode Primarily Unresponsive to Therapy in Elderly Patients: Efficacy of Ginkgo Biloba Extract (Egb 761) in Combination with Antidepressants. Geriatr Forsch 1993; 3: 45-53.
26. FAVA M, MISCHOULAN D. Docosahexanoic Acid in the Prevention and Treatment of Depression. In Mischoulon D, Rosnbaum JF (eds.): Natural Medications for Psychiatric Disorders - Considering the Alternatives, Philadelphia; Lippincott Williams & Wilkins, 2002: 35-42.
27. STOLL AL, LOCKE CA. Omega-3 Fatty Acids in Mood Disorders - A Review of Neurobiologic and Clinical Actions. In: Mischoulon D, Rosenbaum JF (eds): Natural Medications for Psychiatric Disorders. Considering the Alternatives, Philadelphia; Lippincott Williams & Wilkins, 2002; 13-34.
28. HOLMAN RT, JOHNSON SB, OGBURN PL. Deficiency of Essential Fatty Acids and Membrane Fluidity During Pregnancy and Lactation. Proc Natl Acad Sci USA 1991; 88: 4835-9.
29. COHEN LS, ALTSHULER LL. Pharmacologic Management of Psychiatric Illnesses during Pregnancy and Lactation. Psychiatr Clin North Am Annu Drug Ther 1997; 4: 21-60.
30. MAES M, SMITH RS. Fatty Acids, Cytokines and Major Depression. Biol Psychiatry 1998; 43: 313-4.
31. BLOCK E, EDWARDS D. Effects of Plasma Membrane Fluidity on Serotonin Transport by Endothelial Cells. Am J Physiol 1987; 253: C672-C678.
32. HIBBELN JR, UMHAU JC, LINNOILA M et al. A Replication Study of Violent and Nonviolent Subjects: Cerebrospinal Fluid Metabolites of Serotonin and Dopamine are Predicted by plasma Essential Fatty Acids. Biol Psychiatry 1998; 44: 243-9.